Home › Funds › M. Kraus & Co › ABT

M. Kraus & Co position in ABT

ABBOTT LABORATORIES · Health Care

M. Kraus & Co reported holding 75,914 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 2.02% of its reported portfolio and ranking #20 among its reported holdings. M. Kraus & Co has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)75.91K sh
Reported value held$7.50M
Portfolio Weight2.02%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How M. Kraus & Co's ABT position evolved

M. Kraus & Co first disclosed a stake in ABT in Q3 2023 at 84,541 shares (US$8.2M). The position peaked in Q2 2025 at 77,190 shares, worth US$10.5M. Across 13 filings, M. Kraus & Co increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 75,914 shares valued at US$7.5M — a reduction of -1,185 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 84.54K $8.19M New
Q4 2023 84.72K $9.33M Hold
Q1 2024 85.27K $9.69M Add
Q2 2024 83.28K $8.65M Reduce
Q3 2024 81.66K $9.31M Reduce
Q4 2024 80.83K $9.14M Reduce
Q1 2025 78.39K $10.40M Reduce
Q2 2025 77.19K $10.50M Reduce
Q3 2025 76.23K $10.21M Reduce
Q4 2025 75.76K $9.49M Reduce
Q1 2026 76.93K $7.90M Add
Q2 2026 77.10K $7.00M Hold
Q3 2026 75.91K $7.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has M. Kraus & Co held ABT?

M. Kraus & Co has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is M. Kraus & Co's current position in ABT?

As of Q3 2026, M. Kraus & Co holds 75.91K shares of ABT (ABBOTT LABORATORIES), valued at $7.50M, representing 2.02% of its reported portfolio and ranking #20.

Has M. Kraus & Co been buying or selling ABT?

In the latest 13F filing (Q3 2026), M. Kraus & Co reduced its position in ABT. The position peaked in Q2 2025 at 77.19K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.